CCM
CAH icon

Cadence Capital Management’s Cardinal Health CAH Stock Holding History

Cadence Capital Management’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$392K Sell
8,339
-1,767
-17% -$90.7K 0.09% 187
2020
Q2 		$527K Sell
10,106
-28,100
-74% -$1.45M 0.08% 311
2020
Q1 		$1.83M Sell
38,206
-19
-0% -$987 0.31% 75
2019
Q4 		$1.93M Sell
38,225
-10,175
-21% -$526K 0.21% 146
2019
Q3 		$2.28M Sell
48,400
-903
-2% -$41.2K 0.32% 113
2019
Q2 		$2.32M Buy
49,303
+20,084
+69% +$926K 0.23% 135
2019
Q1 		$1.41M Buy
29,219
+490
+2% +$24.5K 0.13% 224
2018
Q4 		$1.28M Sell
28,729
-95,650
-77% -$4.99M 0.13% 228
2018
Q3 		$6.72M Buy
124,379
+71,293
+134% +$3.65M 0.36% 69
2018
Q2 		$2.59M Sell
53,086
-4,972
-9% -$282K 0.15% 164
2018
Q1 		$3.64M Buy
58,058
+15,197
+35% +$1.04M 0.24% 102
2017
Q4 		$2.63M Sell
42,861
-22,344
-34% -$1.38M 0.17% 130
2017
Q3 		$4.36M Buy
65,205
+5,078
+8% +$359K 0.27% 96
2017
Q2 		$4.68M Sell
60,127
-2,616
-4% -$197K 0.32% 77
2017
Q1 		$5.12M Sell
62,743
-52,730
-46% -$4.15M 0.35% 70
2016
Q4 		$8.31M Buy
115,473
+17,347
+18% +$1.25M 0.58% 45
2016
Q3 		$7.62M Buy
98,126
+18,278
+23% +$1.48M 0.56% 50
2016
Q2 		$6.23M Buy
79,848
+46,077
+136% +$3.67M 0.47% 57
2016
Q1 		$2.77M Sell
33,771
-18,036
-35% -$1.47M 0.19% 132
2015
Q4 		$4.63M Sell
51,807
-1,131
-2% -$96K 0.31% 81
2015
Q3 		$4.07M Sell
52,938
-1,538
-3% -$129K 0.29% 99
2015
Q2 		$4.56M Buy
54,476
+1,576
+3% +$139K 0.25% 106
2015
Q1 		$4.78M Sell
52,900
-7,358
-12% -$633K 0.29% 91
2014
Q4 		$4.87M Sell
60,258
-18,885
-24% -$1.49M 0.28% 99
2014
Q3 		$5.93M Sell
79,143
-22,190
-22% -$1.61M 0.31% 96
2014
Q2 		$6.95M Sell
101,333
-1,900
-2% -$129K 0.33% 87
2014
Q1 		$7.22M Sell
103,233
-20,820
-17% -$1.45M 0.3% 93
2013
Q4 		$8.29M Sell
124,053
-16,620
-12% -$1.02M 0.31% 83
2013
Q3 		$7.34M Sell
140,673
-3,420
-2% -$174K 0.25% 179
2013
Q2 		$6.8M Buy
+144,093
New +$6.58M 0.32% 154

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Cadence Capital Management's CAH Position: Q3 2020 in Review

Cadence Capital Management reduced its Cardinal Health (CAH) stake by 17% in Q3 2020, selling an estimated $90.7K and leaving 8,339 shares worth $392K. The position accounts for 0.09% of the portfolio, ranked #187.

Cadence Capital Management first reported a position in CAH in Q2 2013 and has held it in 30 quarters since. The position peaked at $8.31M in Q4 2016. 740 funds tracked by Wall St. Rank hold CAH as of Q3 2020.

  • Cadence Capital Management held 8,339 shares of Cardinal Health worth $392K as of Q3 2020.
  • Cadence Capital Management sold 1,767 Cardinal Health shares in Q3 2020, an estimated $90.7K.
  • Cardinal Health made up 0.09% of Cadence Capital Management's portfolio in Q3 2020, its #187 holding.
  • Cadence Capital Management first reported a position in Cardinal Health in Q2 2013 and has held it in 30 quarters since.
  • Cadence Capital Management's Cardinal Health position peaked at $8.31M in Q4 2016.
  • 740 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.